Share

February 2023; 13 (1) Editorial

Phlebology Implications in Amyotrophic Lateral Sclerosis

Mamede de Carvalho
First published January 19, 2023, DOI: https://doi.org/10.1212/CPJ.0000000000200128
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
32

Share

Article Information

vol. 13 no. 1 e200128
DOI: 
https://doi.org/10.1212/CPJ.0000000000200128
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
2163-0402
Online ISSN: 
2163-0933
History: 
  • Received October 24, 2022
  • Accepted November 9, 2022
  • First Published January 19, 2023.
Copyright & Usage: 
© 2023 American Academy of Neurology

Author Disclosures

    1. Mamede de Carvalho, MD, PhD
  1. Mamede de Carvalho, MD, PhD
    2. Scientific Advisory Boards:

    1. Biogen Idec<br>Cytokinetcs Inc

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. Octapharm<br>Biogen Idec<br>Genzyme<br>Kedrion<br>Pfizer

    Editorial Boards:

    1. Clinical Neurophysiology, Editorial Board - 2004-2010<br>Neurophysiologie Clinique, Editorial Board - 2007- <br>present<br>ALS journal, Editorial Board - 2007- present<br>Clinical Reports in Medicine, Associated Editor 2009 - <br>present<br>Neurology Research International, Associated Editor <br>2009-<br>present<br>BMC Neurology Associated Editor 2018<br>Journal of Alzheimer&#x00B4;s Disease, Associated Editor in <br>2010.

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. Full professor - Faculty Medicine Lisbon<br>Neurophysiologist Senior Consultant - H Santa Maria, Lisbon

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. I have received research grants from FCT (Portugal), <br> JPND (European Union) and H2020 (European Union)

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. I have received research grants from Sociedade Portuguesa <br>de Neurologia

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. Instituto de Fisiologia (MC), Instituto de Medicina Molecular, Centro de Estudos Egas Moniz, Faculdade de Medicina, Univeridade de Lisboa, Portugal; and Department of Neurosciences and Mental Health (MC), Hospital de Santa Maria, Centro Hospitalar Universitário de Lisboa Norte, Portugal.
  1. Correspondence
    Dr. de Carvalho mamedemg{at}gmail.com
View Full Text

Article usage

Article usage: January 2023 to May 2023

AbstractFullPdfSource
Jan 2023315181Highwire
Feb 20235398226Highwire
Mar 20239855Highwire
Apr 20232640Highwire

The Nerve!: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

Alert Me